- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/91 - Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
Patent holdings for IPC class C07D 239/91
Total number of patents in this class: 231
10-year publication summary
|
21
|
14
|
8
|
15
|
15
|
13
|
17
|
10
|
10
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Resverlogix Corp. | 56 |
22 |
| Gilead Sciences, Inc. | 2027 |
8 |
| Inipharm, Inc. | 26 |
7 |
| Novartis AG | 10883 |
5 |
| Centre National de La Recherche Scientifique | 10350 |
5 |
| Hoffmann-La Roche Inc. | 3387 |
4 |
| The Trustees of Columbia University in the City of New York | 3561 |
4 |
| Array BioPharma Inc. | 505 |
4 |
| Council of Scientific & Industrial Research | 1423 |
4 |
| Southern Research Institute | 210 |
4 |
| University of Kansas | 868 |
4 |
| University of Louisville Research Foundation, Inc. | 717 |
4 |
| Merck Patent GmbH | 5850 |
3 |
| Annji Pharmaceutical Co., Ltd. | 15 |
3 |
| Astex Therapeutics Limited | 242 |
3 |
| Ecole Normale Superieure de Lyon | 235 |
3 |
| Forschungsverbund Berlin e.V. | 192 |
3 |
| ICOS Corporation | 17 |
3 |
| The Medical College of Wisconsin, Inc. | 397 |
3 |
| prAna Biotechnology Limited | 13 |
3 |
| Other owners | 132 |